InvestorsHub on MSN
Taysha Advances Rett Syndrome Programme as Pivotal Trial Enrollment Completes (TSHA)
Taysha Gene Therapies Inc (NASDAQ:TSHA) shares rose 3.6% in premarket trading on Monday after the company announced the ...
Recently disclosed longer-term REVEAL Part A data demonstrated broad, multi-domain functional impact that deepened over time ...
Taysha Gene Therapies (TSHA) remains a Buy on strong TSHA-102 Rett data, FDA-aligned pivotal path, and cash to 2028—read the ...
Completed dosing of 17 patients in REVEAL pivotal trial; topline data from 6‑month interim analysis and FDA feedback on next steps toward BLA ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) shares are climbing after the company reported its fiscal year 2023 results after the bell Tuesday. Here's a look at the highlights. The Details: The company ...
View Taysha Gene Therapies, Inc. TSHA stock quote prices, financial information, real-time forecasts, and company news from CNN.
Teisha Matthews, known best for her famed moniker, TSHA, is renowned for her eclectic, emotive and intricate sound that has the ability to transcend boundaries. Today, October 7, she showcases her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results